Skip to main content
. 2021 Mar 12;11(3):420. doi: 10.3390/biom11030420

Figure 4.

Figure 4

Effect of PSE and Phy on MCF-10A, BJ-5ta and HUVECs BrdU (5-bromo-2'-deoxyuridine) incorporation. MCF-10A (A) and BJ-5ta (B) cells were treated with various concentrations of PSE and Phy (10–100 μg/mol) for 72 h. HUVECs were treated with the same range of concentrations of tested compounds in the absence (C) or presence (D) of VEGF (25 ng/mL) for 48 h. Values represent the mean ± standard deviation. (* p < 0.05, ** p < 0.01, *** p < 0.001 compared to control; # p < 0.05, ## p < 0.01 compared to VEGF).